Andrew Ko

9PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSatisfiability and optimisationGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 18, 2026
Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM).

|Aug 14, 2026
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.

|Feb 13, 2026
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.

Xiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu

|Nov 25, 2025
Comprehensive Genomic Profiling for Resectable Pancreatic Cancer: The Earlier the Better?

Andrew H Ko

|Oct 02, 2025
Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at JCO: A Guide for Studies Testing Artificial Intelligence Models.

Ravi B Parikh, Alexia Iasonos, Andrew Ko

|Sep 10, 2025
Bridging the Gap: Molecular Profiling to Guide Treatment Selection in Metastatic Pancreatic Cancer.

Mandana Kamgar, Andrew H Ko

Pageof 2

Frequent Collaborators

3 joint publications

Lawrence Fong

3 joint publications

Bridget P Keenan

2 joint publications

Frank J Hsu

2 joint publications

Erin L Filbert